+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infertility Treatment Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 144 Pages
  • September 2023
  • Region: Global
  • IMARC Group
  • ID: 5633384
The global infertility treatment devices market size reached US$ 424.7 Million in 2022. Looking forward, the publisher expects the market to reach US$ 608.9 Million by 2028, exhibiting a growth rate (CAGR) of 6.11% during 2023-2028.

Infertility is a disease of the male or female reproductive system wherein attempts to achieve pregnancy after 12 months or more fail. It is generally caused by problems in the ejection of semen in the male reproductive system or abnormalities in the ovaries, uterus, fallopian tubes, and the endocrine system of the female reproductive system. It is treated using assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), and artificial insemination methods like intrauterine insemination (IUI). At present, there is a rise in the demand for infertility treatment devices on account of the rising prevalence of conditions like polycystic ovary syndrome (PCOS) around the world.

Infertility Treatment Devices Market Trends:

The increasing number of fertility clinics across the globe represents one of the key factors propelling the growth of the market. Moreover, lack of physical activities on account of sedentary lifestyles has led to the development of chronic diseases, such as diabetes, obesity, and hypertension, which are potential risk factors leading to infertility among men and women. Consequently, there is a rise in the use of ART procedures, such as IVF, which involves the utilization of previously frozen embryos and donor eggs or sperm. This, coupled with the growing availability of numerous infertility treatment devices, is positively influencing the market. Apart from this, key players are introducing technological advancements and developing techniques that improve the conception success rate. They are also increasingly focusing on strategic developments, agreements/partnerships with domestic players, geographical expansions, and mergers and acquisitions (M&A) to increase their presence and widen their customer-base. Some of the other factors contributing to the market growth include declining fertility rates, rising public-private investments and government initiatives to increase the accessibility of infertility treatments.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global infertility treatment devices market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on type, patient type and end user.

Breakup by Type:

  • Sperm Separation Devices
  • Ovum Aspiration Pumps
  • Sperm Analyzer Systems
  • Micromanipulator Systems
  • Incubators
  • Cryosystems
  • Imaging Systems
  • Microscopes
  • Others

Breakup by Patient Type:

  • Female Infertility Treatment
  • Male Infertility Treatment

Breakup by End User:

  • Fertility Clinics
  • Hospitals and Other Healthcare Facilities
  • Clinical Research Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ab Scientific Ltd, Cook Group Incorporated, Coopersurgical Inc. (The Cooper Companies Inc.), Eppendorf, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne Ltd., Kitazato Corporation, Rocket Medical plc, Thermo Fisher Scientific, Thomas Medical (Medgyn Products Inc.), Vitrolife.

Key Questions Answered in This Report:

  • How has the global infertility treatment devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global infertility treatment devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the patient type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global infertility treatment devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Infertility Treatment Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Sperm Separation Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ovum Aspiration Pumps
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Sperm Analyzer Systems
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Micromanipulator Systems
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Incubators
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Cryosystems
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Imaging Systems
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Microscopes
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Others
6.9.1 Market Trends
6.9.2 Market Forecast
7 Market Breakup by Patient Type
7.1 Female Infertility Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Male Infertility Treatment
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Fertility Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals and Other Healthcare Facilities
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinical Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Ab Scientific Ltd
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Cook Group Incorporated
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Coopersurgical Inc. (The Cooper Companies Inc.)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Eppendorf
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Esco Micro Pte. Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Genea Limited
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Hamilton Throne Ltd.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Kitazato Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Rocket Medical plc
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Thermo Fisher Scientific
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Thomas Medical (Medgyn Products Inc.)
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Vitrolife
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials

Companies Mentioned

  • Ab Scientific Ltd
  • Cook Group Incorporated
  • Coopersurgical Inc. (The Cooper Companies Inc.)
  • Eppendorf
  • Esco Micro Pte. Ltd.
  • Genea Limited
  • Hamilton Throne Ltd.
  • Kitazato Corporation
  • Rocket Medical plc
  • Thermo Fisher Scientific
  • Thomas Medical (Medgyn Products Inc.)
  • Vitrolife.

Methodology

Loading
LOADING...

Table Information